Ambeed.cn

首页 / 抑制剂/激动剂 / / ROR

货号 产品名 纯度
A489496 现货 Neoruscogenin/新鲁斯可皂苷元

Neoruscogenin is a natural sapogenin isolated from Butcher’s broom (R. rhizoma) that can relieve chronic venous disorders.

99%
A887606 现货 SR2211

SR2211 is a potent, selective synthetic RORγ modulator and functions as an inverse agonist, with a Ki of 105 nM and an IC50 of ~320 nM.

99%
A1177063 现货 S18-000003

99%
A1364841 现货 RORγt Inverse agonist 6

98%
A1503551 现货 Cedirogant

99%
A1549932 现货 Bevurogant

98%
A262784 现货 3-Oxo-5β-cholanoic acid/熊去氧胆酸杂质28

99%
A769555 现货 GSK805

RORγt-IN-1 is a potent, orally bioavailable RORγt inhibitor with pIC50 of 8.4 and > 8.2 for RORγ FRET assay and Th17 assay.

98%
A951251 现货 (±)-ML 209

(±)-ML 209 is a RORγt inverse agonist with IC50 of 460 nM.

99%
A240693 现货 SR1001

SR1001 is a selective RORα and RORγ inverse agonist and inhibits TH17 cell differentiation and function.

99%
A576988 现货 GSK2981278

GSK2981278 is a retinoid-related orphan receptor gamma (RORy) modulator.

99%
A244776 现货 SR-1078

SR-1078 is an agonist of RORα and RORγ and can increase transcriptional activity of RORα with 2 μM.

99%
A129464 现货 SR3335

SR3335 can selectively bind to RORα and competitively inhibit the binding of 25-hydroxycholesterol to the ligand binding domain with Ki of 220 nM.

99%
A1167892 现货 PF-06747711

PF-06747711 is a potent, selective, and orally active retinoic acid receptor-related orphan C2 (RORC2, also known as RORγt) inverse agonist, with an IC50 of 4.1 nM. Anti-skin inflammatory activity.

99%
A627902 现货 Cintirorgon

LYC-55716 is agonist of RAR-related orphan receptor γ (RORγ).

99%
A1281887 现货 RORγ inverse agonist 1

98%
A1176758 RORγt Inverse agonist 2

95%
A1177096 AZD-0284

99%
A1246287 RORγt Inverse agonist 8

98%
A1257142 TMP780

99%
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。